H5N1 influenza virulence, pathogenicity and transmissibility: What do we know?

Future Virology

Volumn 10, Issue 8, 2015, Pages 971-980

  Neumann, Gabriele ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

H5N1; HA; influenza; NS1; pathogenicity; PB1 F2; PB2; virulence

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; NONSTRUCTURAL PROTEIN 1; PB1 F2 PROTEIN; POLYMERASE PB2 PROTEIN; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS PROTEIN;

BINDING AFFINITY; DEATH; GENE MUTATION; HOST RANGE; HUMAN; INFLUENZA A (H5N1); INFLUENZA A VIRUS (H5N1); INFLUENZA VIRUS; INNATE IMMUNITY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRULENCE; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 84940659978     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.15.62     Document Type: Review

References (93)

1. Gomaa MR, Kayed AS, Elabd MA, et al. Avian influenza A(H5N1) and A(H9N2) seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study. J. Infect. Dis. 211(9), 1399-1407 (2015
2. Uyeki TM, Nguyen DC, Rowe T, et al. Seroprevalence of antibodies to avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam, 2001. PLoS ONE. 7(8), e43948 (2012
3. Herfst S, Schrauwen EJ, Linster M, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 336(6088), 1534-1541 (2012
4. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 486(7403), 420-428 (2012
5. Zhang Y, Zhang Q, Kong H, et al. H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet. Science. 340(6139), 1459-1463 (2013
6. Chen LM, Blixt O, Stevens J, et al. In vitro evolution of H5N1 avian influenza virus toward human-Type receptor specificity. Virology. 422(1), 105-113 (2012
7. Jhung MA, Nelson DI. Outbreaks of avian influenza A (H5N2), (H5N8), and (H5N1) among birds - United States, December 2014-January 2015. MMWR Morb. Mortal. Wkly. Rep. 64(4), 111 (2015
8. Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 279(5349), 393-396 (1998
9. Claas EC, De Jong JC, Van Beek R, Rimmelzwaan GF, Osterhaus AD. Human influenza virus A/Hongkong/156/97 (H5N1) infection. Vaccine. 16(9-10), 977-978 (1998
10. Claas EC, Osterhaus AD, Van Beek R, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 351(9101), 472-477 (1998
11. WHO/FAO/OIE/US-CDC/US-NAMRU-3/.UNICEF. Joint high-level mission on the current H5N1 situation in Egypt. www.emro.who.int/images/stories/.executive-summary-14-may-2015.pdf
12. Guan Y, Peiris JS, Lipatov AS, et al. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc. Natl Acad. Sci. USA. 99(13), 8950-8955 (2002
13. Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 430(6996), 209-213 (2004
14. Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc. Natl Acad. Sci. USA. 103(8), 2845-2850 (2006
15. Sonnberg S, Webby RJ, Webster RG. Natural History of Highly Pathogenic Avian Influenza H5N1. Virus Res. 178(1), 63-77 (2013
16. Neumann G, Green MA, Macken CA. Evolution of highly pathogenic avian H5N1 influenza viruses and the emergence of dominant variants. J. Gen. Virol. 91(Pt 8), 1984-1995 (2010
17. Wong FY, Phommachanh P, Kalpravidh W, et al. Reassortant highly pathogenic influenza A(H5N6) virus in Laos. Emerg. Infect. Dis. 21(3), 511-516 (2015
18. Wu H, Lu R, Peng X, et al. Novel reassortant highly pathogenic H5N6 avian influenza viruses in poultry in China. Infect. Genet. Evol. 31C, 64-67 (2015
19. Bi Y, Mei K, Shi W, et al. Two novel reassortants of avian influenza A(H5N6) virus in China. J. Gen. Virol. 96(Pt 5), 975-981 (2015
20. Franca MS, Brown JD. Influenza pathobiology and pathogenesis in avian species. Curr. Top. Microbiol. Immunol. 385, 221-242 (2014
21. Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Fields Virology. Knipe DM, Howley PM, Cohen JI, et al. (Eds). Lippincott Williams & Wilkins, PA, USA, 1186-1243 (2013
22. Watanabe Y, Ibrahim MS, Suzuki Y, Ikuta K. The changing nature of avian influenza A virus (H5N1). Trends Microbiol. 20(1), 11-20 (2012
23. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature. 440(7083), 435-436 (2006
24. Baum LG, Paulson JC. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem. Suppl. 40 35-38 (1990
25. Nicholls JM, Chan MC, Chan WY, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract.Nat. Med. 13(2), 147-149 (2007
26. Yao L, Korteweg C, Hsueh W, Gu J. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J. 22(3), 733-740 (2008
27. Maines TR, Chen LM, Van Hoeven N, et al
28. Burke DF, Smith DJ. A recommended numbering scheme for influenza A HA subtypes. PLoS ONE. 9(11), e112302 (2014
29. Linster M, Van Boheemen S, De Graaf M, et al. Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell. 157(2), 329-339 (2014
30. Fan S, Hatta M, Kim JH, et al. Novel residues in avian influenza virus PB2 protein affect virulence in mammalian hosts. Nat.Commun. 5, 5021 (2014
31. Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T. PB2 residue 271 plays a key role in enhanced polymerase activity of Influenza A viruses in mammalian host cells. J. Virol. 84(9), 4395-4406 (2010
32. Mehle A, Doudna JA. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc. Natl Acad. Sci. USA. 106(50), 21312-21316 (2009
33. Yamada S, Hatta M, Staker BL, et al. Biological and structural characterization of a host-Adapting amino acid in influenza virus. PLoS Pathog. 6(8), e1001034 (2010
34. Subbarao EK, London W, Murphy BR. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 67(4), 1761-1764 (1993
35. Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 293(5536), 1840-1842 (2001
36. Hatta M, Hatta Y, Kim JH, et al. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 3(10), 1374-1379 (2007
37. Li Z, Chen H, Jiao P, et al. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J. Virol. 79(18), 12058-12064 (2005
38. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl Acad. Sci. USA. 102(51), 18590-18595 (2005
39. Gabriel G, Herwig A, Klenk HD. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog. 4(2), e11 (2008
40. Jiao P, Tian G, Li Y, et al. A single-Amino-Acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J. Virol. 82(3), 1146-1154 (2008
41. Long JX, Peng DX, Liu YL, Wu YT, Liu XF. Virulence of H5N1 avian influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural gene. Virus Genes. 36(3), 471-478 (2008
42. Li W, Wang G, Zhang H, et al. Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNFalpha response and p53 activity. Cell. Mol. Immunol. 7(3), 235-242 (2010
43. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8(9), 950-954 (2002
44. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol. Cell. 1(7), 991-1000 (1998
45. Das K, Ma LC, Xiao R, et al. Structural basis for suppression of a host antiviral response by influenza A virus. Proc. Natl Acad. Sci. USA. 105(35), 13093-13098 (2008
46. Twu KY, Kuo RL, Marklund J, Krug RM. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J. Virol. 81(15), 8112-8121 (2007
47. Dankar SK, Miranda E, Forbes NE, et al. Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30. Virol. J. 10 243 (2013
48. Dankar SK, Wang S, Ping J, et al. Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence. Virol. J. 8, 13 (2011
49. Spesock A, Malur M, Hossain MJ, et al. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J. Virol. 85(14), 7048-7058 (2011
50. Kainov DE, Muller KH, Theisen LL, Anastasina M, Kaloinen M, Muller CP. Differential effects of NS1 proteins of human pandemic H1N1/2009, avian highly pathogenic H5N1, and low pathogenic H5N2 influenza A viruses on cellular pre-mRNA polyadenylation and mRNA translation. J. Biol. Chem. 286(9), 7239-7247 (2011
51. Fan S, Macken CA, Li C, et al. Synergistic effect of the PDZ and p85beta-binding domains of the NS1 protein on virulence of an avian H5N1 influenza A virus. J. Virol. 87(9), 4861-4871 (2013
52. Imai H, Shinya K, Takano R, et al. The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog. 6(9), e1001106 (2010
53. Obenauer JC, Denson J, Mehta PK, et al. Large-scale sequence analysis of avian influenza isolates. Science. 311(5767), 1576-1580 (2006
54. Liu H, Golebiewski L, Dow EC, Krug RM, Javier RT, Rice AP. The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting scribble. J. Virol. 84(21), 11164-11174 (2010
55. Yu J, Li X, Wang Y, et al. Pdlim2 selectively interacts with the PDZ binding motif of highly pathogenic avian H5N1 influenza A virus NS1. PLoS ONE. 6(5), e19511 (2011
56. Golebiewski L, Liu H, Javier RT, Rice AP. The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J. Virol. 85(20), 10639-10648 (2011
57. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA. A new influenza virus virulence determinant: the NS1 protein four C-Terminal residues modulate pathogenicity. Proc. Natl Acad. Sci. USA. 105(11), 4381-4386 (2008
58. Zielecki F, Semmler I, Kalthoff D, et al. Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-Terminal ESEV motif in the viral NS1 protein. J. Virol. 84(20), 10708-10718 (2010
59. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3(10), 1414-1421 (2007
60. Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, Katze MG. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J. Virol. 85(2), 652-662 (2011
61. Schmolke M, Manicassamy B, Pena L, et al. Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog. 7(8), e1002186 (2011
62. Hai R, Schmolke M, Varga ZT, et al. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J. Virol. 84(9), 4442-4450 (2010
63. Yang H, Chang JC, Guo Z, et al. Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins. J. Virol. 88(9), 4828-4838 (2014
64. FDA. Recalls (Biologics). www.fda.gov/biologicsbloodvaccines/.safetyavailability/recalls/default.htm
65. Government of Canada. New Expiry Date for Unused Adjuvanted H1N1 Vaccine (Arepanrix). www.healthycanadians.gc.ca/recall-Alertrappel-Avis/hc-sc/2010/13496a-eng.php
66. Chen H, Smith GJ, Zhang SY, et al. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature. 436(7048), 191-192 (2005
67. Chen H, Li Y, Li Z, et al. Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J. Virol. 80(12), 5976-5983 (2006
68. Liu J, Xiao H, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science. 309(5738), 1206 (2005
69. Centers for Disease Control and Prevention. H5N1 genetic changes inventory. www.cdc.gov/flu/avianflu/H5N1/inventory. htm
70. Garcia-Sastre A, Egorov A, Matassov D, et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology. 252(2), 324-330 (1998
71. Shaw ML, Palese P. Orthomyxoviridae. In: Fields Virology. Knipe DM, Howley PM, Cohen JI, et al. (Eds). Lippincott Williams & Wilkins, PA, USA, 1151-1185 (2013
72. Ma W, Brenner D, Wang Z, et al. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J. Virol. 84(4), 2122-2133 (2010
73. Nacken W, Anhlan D, Hrincius ER, et al. Activation of c-jun N-Terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1. J. Virol. 88(16), 8843-8852 (2014
74. Ludwig S, Wang X, Ehrhardt C, et al. The influenza A virus NS1 protein inhibits activation of Jun N-Terminal kinase and AP-1 transcription factors. J. Virol. 76(21), 11166-11171 (2002
75. Nacken W, Ehrhardt C, Ludwig S. Small molecule inhibitors of the c-Jun N-Terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. BiolChem. 393(6), 525-534 (2012
76. Ehrhardt C, Wolff T, Pleschka S, et al. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J. Virol. 81(7), 3058-3067 (2007
77. Hrincius ER, Dierkes R, Anhlan D, Wixler V, Ludwig S, Ehrhardt C. Phosphatidylinositol-3-kinase (PI3k) is activated by influenza virus vRNA via the pathogen pattern receptor RIG-I to promote efficient type I interferon production. Cell. Microbiol. 13(12), 1907-1919 (2011
78. Chen W, Calvo PA, Malide D, et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7(12), 1306-1312 (2001
79. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P. Influenza Virus PB1-F2 Protein Induces Cell Death Through Mitochondrial Ant3 and Vdac1. PLoS Pathog. 1(1), e4 (2005
80. Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, Zimmerberg J. PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J. Virol. 78(12), 6304-6312 (2004
81. Henkel M, Mitzner D, Henklein P, et al. The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel. PLoS ONE. 5(6), e11112 (2010
82. Mcauley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, Mccullers JA. PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog. 6(7), e1001014 (2010
83. Chen CJ, Chen GW, Wang CH, Huang CH, Wang YC, Shih SR. Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J. Virol. 84(19), 10051-10062 (2010
84. Varga ZT, Ramos I, Hai R, et al. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 7(6), e1002067 (2011
85. Dudek SE, Wixler L, Nordhoff C, et al. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol. Chem. 392(12), 1135-1144 (2011
86. Le Goffic R, Bouguyon E, Chevalier C, et al. Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells. J. Immunol. 185(8), 4812-4823 (2010
87. Le Goffic R, Leymarie O, Chevalier C, et al. Transcriptomic analysis of host immune and cell death responses associated with the influenza A virus PB1-F2 protein. PLoS Pathog. 7(8), e1002202 (2011
88. Varga ZT, Grant A, Manicassamy B, Palese P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J. Virol. 86(16), 8359-8366 (2012
89. Mcauley JL, Tate MD, Mackenzie-Kludas CJ, et al. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog. 9(5), e1003392 (2013
90. Mcauley JL, Hornung F, Boyd KL, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe. 2(4), 240-249 (2007
91. Iverson AR, Boyd KL, Mcauley JL, Plano LR, Hart ME, Mccullers JA. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J. Infect. Dis. 203(6), 880-888 (2011
92. Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell. Microbiol. 10(5), 1140-1152 (2008
93. Jernigan DB, Cox NJ. H7N9: Preparing for the unexpected in influenza. Annu. Rev. Med. 66 361-371 (2015